CTRI/2012/08/002936
Completed
未知
Prevalence of Host and Viral Genotypes in Patients withChronic Hepatitis C and Chronic Hepatitis B Infection in India
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Gilead Sciences Inc
- Enrollment
- 1000
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •ï?? Willing and able to provide written informed consent
- •ï?? Male or female, age \>\=18 years old
- •ï?? Willing and able to comply with the visit procedures
- •ï?? Prior diagnosis of chronic HCV infection or chronic HBV infection; a history of chronic HCV or HBV infection provided by a subject or a subjectâ??s health provider is sufficient; documentation not required At each center, no more than 40% of the patients with previously known chronic HBV enrolled in the study may be inactive carriers (i.e., HBsAg positive with HBV DNA \< 2000 IU/ml).
Exclusion Criteria
- •ï?? History of difficulty with blood collection and/or poor
- •venous access for the purposes of phlebotomy.
- •ï?? History of bleeding disorder
- •ï?? Blood loss requiring transfusion or 3 g/dL decrease in
- •hemoglobin within 4 days of the visit
- •ï?? Knowingly co\-infected with HCV/HBV or with HIV
- •ï?? Currently undergoing therapy for chronic hepatitis C or chronic hepatitis B. For the purposes of the study, the last dose of prior HCV or HBV therapy (if applicable) must have been administered 30 days prior to the study visit date for this trial.
- •ï?? Currently receiving treatment with any other investigational agent or device. For the purposes of the study, the last dose of any investigational agent or utilization of any investigational device must have been administered 30 days prior to the study visit date for this trial.
- •ï?? Enrolled in another clinical study evaluating a treatment or procedure. Subjects may be enrolled in another clinical study evaluating a treatment or procedure \>\=24 hours following the completion of the study visit assessments and procedures for this trial.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The analysis of the host genetic and viral pathological factors causing severe Enterovirus infectioHand, foot, and mouth diseaseJPRN-UMIN000015864Graduate school of Medical Sciences, Kanazawa University400
Unknown
Not Applicable
Study of factors of virus and host sassociated with severe Enterovirus diseasesEnterovirus71 infectionJPRN-UMIN000023742Tokyo Metropolitan Children's Medical Center100
Completed
Not Applicable
Incidence and risk factors of viral infections in patients after liver transplantatioPatients undergoing orthotopic liver transplantation from deceased donorsK74.6C22.0Other and unspecified cirrhosis of liverLiver cell carcinomaDRKS00006754Klinik für Anaesthesiologie Universitätsklinikum Heidelberg51
Recruiting
Not Applicable
Study of Acquired Viral Mutations in Chronic Hepatitis B Patients on Antihepadnaviral TherapyChronic Hepatitis BInflammatory and Immune System - LiverACTRN12607000366459Gilead Sciences Pty Ltd800
Completed
Not Applicable
The analysis of viral genomes in patients with exacerbated aspirin-exacerbated respiratory disease (AERD)Aspirin-exacerbated respiratory disease (AERD)JPRN-UMIN000020838Sagamihara National Hospital60